ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CGEN Compugen Ltd

2.60
0.06 (2.36%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Compugen Ltd CGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 2.36% 2.60 19:16:55
Open Price Low Price High Price Close Price Prev Close
2.54 2.50 2.625 2.58 2.54
more quote information »

Recent News

Date Time Source Heading
3/11/202407:00PRNUSCompugen Selected for two Oral Presentations at the Keystone..
3/06/202407:00PRNUSCompugen to Present Data Reflecting its Diversified..
3/05/202416:06EDGAR2Form 20-F - Annual and transition report of foreign private..
3/05/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/05/202407:00PRNUSCompugen Reports Fourth Quarter and Full Year 2023 Results
3/05/202406:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
2/26/202407:00PRNUSCompugen to Present at the Leerink Partners Global Biopharma..
2/20/202407:00PRNUSCompugen to Release Fourth Quarter and Full Year 2023..
2/15/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/15/202407:00PRNUSCompugen Announces Appointment of Michelle Mahler M.D. as..
1/08/202407:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/08/202407:05PRNUSCompugen to Receive $10 Million Milestone Payment Following..
1/08/202407:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
12/19/202309:30APSStrong Open For Biotech Following Exclusive Agreement..
12/19/202307:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/19/202307:10PRNUSCompugen will be Eligible to Receive $10 Million Milestone..
12/19/202307:05PRNUSCompugen to Host Conference Call to Discuss Exclusive..
12/19/202307:00BWGilead and Compugen Announce Exclusive License Agreement for..
11/07/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202307:00PRNUSCompugen Reports Third Quarter 2023 Results
11/06/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202307:00PRNUSCompugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity..
11/03/202316:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/03/202316:35PRNUSCompugen Announces Receipt of Nasdaq Minimum Bid Price..
10/31/202309:00PRNUSCompugen to Present New Data at SITC 2023 Suggesting Leading..
10/24/202307:00PRNUSCompugen to Release Third Quarter 2023 Results on Tuesday,..
10/03/202307:00PRNUSCompugen to Present at Single Cell Genomics 2023 Meeting
10/02/202307:00PRNUSCompugen Expands Intellectual Property with New Japanese..
9/27/202309:00PRNUSCompugen to Present New Clinical and Pre-Clinical Data in..
9/21/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/31/202307:00PRNUSCompugen to Present at the H.C. Wainwright 25th Annual..
8/23/202308:00EDGAR2Form 20-F/A - Annual and transition report of foreign..
8/07/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/07/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/07/202307:00PRNUSCompugen Reports Second Quarter 2023 Results
7/24/202307:00PRNUSCompugen to Release Second Quarter 2023 Results on Monday,..
7/17/202307:00PRNUSCompugen Wins on PVRIG European Patent Opposition Pursued by..
6/22/202307:00PRNUSCompugen Doses First Patient in Triple Immunotherapy..
6/13/202307:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
6/05/202307:00PRNUSCompugen's COM701 (anti-PVRIG) Demonstrates Preliminary..
5/15/202307:00PRNUSCompugen Reports First Quarter 2023 Results
5/11/202307:00PRNUSCompugen to Host DNAM-1 Axis Virtual Investor Event with KOL..
5/09/202307:00PRNUSCompugen to Present at the JMP Securities Life Sciences..
5/01/202307:00PRNUSCompugen to Release First Quarter 2023 Results on Monday,..
4/27/202307:00PRNUSCompugen to Present New Clinical Data Showing Preliminary..
4/26/202307:00PRNUSCompugen to Present Data on its Lead Pre-Clinical Asset..

Your Recent History

Delayed Upgrade Clock